Lung cancer: Current and new drug delivery systems

Lung cancer is still a prevalent chronic illness worldwide, which has led to a thorough investigation of its complexities, therapies, and cutting-edge strategies. This excerpt explores several aspects related to lung cancer, beginning with an overview of the disease's characteristics and effects along with a review of global data and significant variables influencing the incidence of lung cancer. It is imperative to comprehend the cellular mechanisms that stimulate the growth of lung cancer. The complex molecular pathways concerned, available therapies, categorized into pharmaceutical, biopharmaceutical, and surgical interventions etc. all play a major role in the eradication of this disease. To effectively combat lung cancer, data from the literature presenting novel approaches and dosage forms such as liposomes, polymeric nanoparticles, lipid nanoparticles, carbon nanotubes, dendrimers, nanoemulsions, and oral dosage forms are analyzed alongside currently available therapies. The significance of interdisciplinary collaboration and continuous research endeavors in effectively addressing lung cancer is underscored.